D
Dicken S.C. Ko
Researcher at Harvard University
Publications - 93
Citations - 3632
Dicken S.C. Ko is an academic researcher from Harvard University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 21, co-authored 86 publications receiving 3355 citations. Previous affiliations of Dicken S.C. Ko include Brown University & Aristotle University of Thessaloniki.
Papers
More filters
Journal ArticleDOI
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
Tatsuo Kawai,A. Benedict Cosimi,Thomas R. Spitzer,Nina Tolkoff-Rubin,Manikkam Suthanthiran,Susan L. Saidman,Juanita Shaffer,Frederic I. Preffer,Ruchuang Ding,Vijay K. Sharma,Jay A. Fishman,Bimalangshu R. Dey,Dicken S.C. Ko,Martin Hertl,Nelson Goes,Waichi Wong,Winfred W. Williams,Robert B. Colvin,Megan Sykes,David H. Sachs +19 more
TL;DR: Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen, and it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation.
Journal Article
Influence of Vesicle Size, Lipid Composition, and Drug-to-Lipid Ratio on the Biological Activity of Liposomal Doxorubicin in Mice
Lawrence D. Mayer,Linda C.L. Tai,Dicken S.C. Ko,Dana Masin,Richard S. Ginsberg,Pieter R. Cullis,Marcel B. Bally +6 more
TL;DR: The results suggest that the stability of liposomally entrapped doxorubicin in the circulation is an important factor in the toxicity of this drug in liposomal form.
Journal ArticleDOI
Effective Treatment of Lymphedema of the Extremities
TL;DR: These patients typically report a significant recovery from their previous cosmetic and functional impairments, and also from the psychosocial limitations they experienced from a physical stigma they felt was often trivialized by the medical and payor communities.
Journal ArticleDOI
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
William C. Goggins,Manuel Pascual,John A. Powelson,Colm C. Magee,Nina Tolkoff-Rubin,Mary Lin Farrell,Dicken S.C. Ko,Winfred W. Williams,Anil Chandraker,Francis L. Delmonico,Hugh Auchincloss,A. Benedict Cosimi +11 more
TL;DR: It is indicated that intraoperative Thymoglobulin administration, in adult cadaveric renal transplant recipients, is associated with a significant decrease in DGF, better early allograft function in the first month posttrans transplant, and a decreased posttransplant hospital length of stay.
Journal ArticleDOI
Outcome of Kidney Transplantation Using Expanded Criteria Donors and Donation After Cardiac Death Kidneys: Realities and Costs
Reza F. Saidi,Nahel Elias,Tatsuo Kawai,Martin Hertl,M L Farrell,Nelson Goes,Waichi Wong,Choli Hartono,Jay A. Fishman,Camille N. Kotton,Nina Tolkoff-Rubin,Francis L. Delmonico,Cosimi Ab,Dicken S.C. Ko +13 more
TL;DR: Although the observations support the utilization of ECD and DCD kidneys, these transplants are associated with increased costs and resource utilization and revised reimbursement guidelines will be required for centers that utilize these organs.